GlassScriptPhysician profile
Rolando E Vega
NPI 1134182488
$369.37
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.20 · 2020: $24.12 · 2021: $43.30 · 2022: $50.64 · 2023: $122 · 2024: $32.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $90.00 · Food and Beverage: $64.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $90.00 |
| Food and Beverage | $64.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $97.13 | 2021-2023 | Liletta |
| Astellas Pharma US INC | $90.00 | 2023 | |
| Mission Pharmacal Company | $65.39 | 2019-2020 | |
| Coopersurgical, INC. | $26.91 | 2021-2024 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $23.72 | 2019 | |
| Glaxosmithkline, LLC. | $19.42 | 2019 | |
| Evofem Biosciences, INC. | $17.63 | 2021 | |
| Sage Therapeutics, LLC | $16.38 | 2024 | |
| Cumberland Pharmaceuticals, INC. | $12.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rolando Vega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.